A Study of Azelaic Acid (AzA) 15% Gel in the Treatment of Seborrheic Dermatitis of the Face

A Double-Blind, Randomized, Vehicle-Controlled, Six-Week Exploratory Multicenter Pilot Study of the Efficacy and Safety of Azelaic Acid (AzA) 15% Gel in the Topical Treatment of Mild to Moderate Seborrheic Dermatitis of the Face

This study is to determine whether a medication on the market for other indications is effective and safe in treating seborrheic dermatitis of the face.

To test the efficacy and safety of azelaic acid 15% gel in the treatment of seborrheic dermatitis of the face

Inclusion Criteria:

- Stable or exacerbating seborrheic dermatitis in the facial area

Exclusion Criteria:

• Psoriasis
• Atopic dermatitis
• Facial acne and rosacea
• Dermatophytic skin infections
• Parkinson's disease
• Known immunosuppression; HIV infection
• Any condition requiring continuous systemic or topical corticosteroid or antimycotic therapy
• Continuous asthma inhalation treatment requiring > 800 mg corticosteroids
• Any severe disease likely to interfere with the conduct or the planned termination of the study